Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Simulating the Effect of Spectroscopic MRI as a Metric for Radiation Therapy Planning in Patients with Glioblastoma.

Cordova JS, Kandula S, Gurbani S, Zhong J, Tejani M, Kayode O, Patel K, Prabhu R, Schreibmann E, Crocker I, Holder CA, Shim H, Shu HK.

Tomography. 2016 Dec;2(4):366-373. doi: 10.18383/j.tom.2016.00187.

2.

Non-invasive metabolic imaging of brain tumours in the era of precision medicine.

Kim MM, Parolia A, Dunphy MP, Venneti S.

Nat Rev Clin Oncol. 2016 Dec;13(12):725-739. doi: 10.1038/nrclinonc.2016.108. Epub 2016 Jul 19. Review.

3.

Radiotherapy planning using MRI.

Schmidt MA, Payne GS.

Phys Med Biol. 2015 Nov 21;60(22):R323-61. doi: 10.1088/0031-9155/60/22/R323. Epub 2015 Oct 28.

4.

Imaging radiation response in tumor and normal tissue.

Rafat M, Ali R, Graves EE.

Am J Nucl Med Mol Imaging. 2015 Jun 15;5(4):317-32. eCollection 2015. Review.

5.

Hypercellularity Components of Glioblastoma Identified by High b-Value Diffusion-Weighted Imaging.

Pramanik PP, Parmar HA, Mammoser AG, Junck LR, Kim MM, Tsien CI, Lawrence TS, Cao Y.

Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):811-9. doi: 10.1016/j.ijrobp.2015.02.058. Epub 2015 Mar 26.

6.

Advanced magnetic resonance imaging methods for planning and monitoring radiation therapy in patients with high-grade glioma.

Lupo JM, Nelson SJ.

Semin Radiat Oncol. 2014 Oct;24(4):248-58. doi: 10.1016/j.semradonc.2014.06.008. Epub 2014 Jul 26. Review.

7.

Volumetric spectroscopic imaging of glioblastoma multiforme radiation treatment volumes.

Parra NA, Maudsley AA, Gupta RK, Ishkanian F, Huang K, Walker GR, Padgett K, Roy B, Panoff J, Markoe A, Stoyanova R.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):376-84. doi: 10.1016/j.ijrobp.2014.03.049. Epub 2014 Jul 24.

8.

Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies.

Phan LM, Yeung SC, Lee MH.

Cancer Biol Med. 2014 Mar;11(1):1-19. doi: 10.7497/j.issn.2095-3941.2014.01.001. Review.

9.

Measuring mitochondrial metabolism in rat brain in vivo using MR Spectroscopy of hyperpolarized [2-¹³C]pyruvate.

Park JM, Josan S, Grafendorfer T, Yen YF, Hurd RE, Spielman DM, Mayer D.

NMR Biomed. 2013 Oct;26(10):1197-203. doi: 10.1002/nbm.2935. Epub 2013 Apr 2.

10.

Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement.

Zhou J, Zhu H, Lim M, Blair L, Quinones-Hinojosa A, Messina SA, Eberhart CG, Pomper MG, Laterra J, Barker PB, van Zijl PC, Blakeley JO.

J Magn Reson Imaging. 2013 Nov;38(5):1119-28. doi: 10.1002/jmri.24067. Epub 2013 Feb 25.

11.

Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging.

Li Y, Lupo JM, Parvataneni R, Lamborn KR, Cha S, Chang SM, Nelson SJ.

Neuro Oncol. 2013 May;15(5):607-17. doi: 10.1093/neuonc/nos334. Epub 2013 Feb 7.

12.

Convex non-negative matrix factorization for brain tumor delimitation from MRSI data.

Ortega-Martorell S, Lisboa PJ, Vellido A, Simões RV, Pumarola M, Julià-Sapé M, Arús C.

PLoS One. 2012;7(10):e47824. doi: 10.1371/journal.pone.0047824. Epub 2012 Oct 23.

13.

Growth properties of SF188/V+ human glioma in rats in vivo observed by magnetic resonance imaging.

Grossman R, Tyler B, Brem H, Eberhart CG, Wang S, Fu DX, Wen Z, Zhou J.

J Neurooncol. 2012 Dec;110(3):315-23. doi: 10.1007/s11060-012-0974-5. Epub 2012 Sep 27.

14.

Spatial characteristics of newly diagnosed grade 3 glioma assessed by magnetic resonance metabolic and diffusion tensor imaging.

Ozturk-Isik E, Pirzkall A, Lamborn KR, Cha S, Chang SM, Nelson SJ.

Transl Oncol. 2012 Feb;5(1):10-8. Epub 2012 Feb 1.

15.

Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.

Nelson SJ.

NMR Biomed. 2011 Jul;24(6):734-49. doi: 10.1002/nbm.1669. Epub 2011 Apr 27. Review.

16.

Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research.

Kurhanewicz J, Vigneron DB, Brindle K, Chekmenev EY, Comment A, Cunningham CH, Deberardinis RJ, Green GG, Leach MO, Rajan SS, Rizi RR, Ross BD, Warren WS, Malloy CR.

Neoplasia. 2011 Feb;13(2):81-97.

17.

Metabolic tumor imaging using magnetic resonance spectroscopy.

Glunde K, Bhujwalla ZM.

Semin Oncol. 2011 Feb;38(1):26-41. doi: 10.1053/j.seminoncol.2010.11.001. Review.

18.

The INTERPRET Decision-Support System version 3.0 for evaluation of Magnetic Resonance Spectroscopy data from human brain tumours and other abnormal brain masses.

Pérez-Ruiz A, Julià-Sapé M, Mercadal G, Olier I, Majós C, Arús C.

BMC Bioinformatics. 2010 Nov 29;11:581. doi: 10.1186/1471-2105-11-581.

19.

Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy.

Li C, Penet MF, Wildes F, Takagi T, Chen Z, Winnard PT, Artemov D, Bhujwalla ZM.

ACS Nano. 2010 Nov 23;4(11):6707-16. doi: 10.1021/nn102187v. Epub 2010 Oct 19.

20.

Imaging of brain tumors: MR spectroscopy and metabolic imaging.

Horská A, Barker PB.

Neuroimaging Clin N Am. 2010 Aug;20(3):293-310. doi: 10.1016/j.nic.2010.04.003. Review.

Supplemental Content

Support Center